Cargando…

Azoospermia and the cancer patient: are there any options?

Detalles Bibliográficos
Autores principales:	Kovac, Jason R, Lipshultz, Larry I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Invited Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854091/ https://www.ncbi.nlm.nih.gov/pubmed/27048789 http://dx.doi.org/10.4103/1008-682X.179248

Ejemplares similares

The benefits of understanding complementary medicine options for patients with male factor infertility
por: Wu, Christopher, et al.
Publicado: (2016)

Are genetic biomarkers the future of male fertility testing?
por: Kovac, Jason R, et al.
Publicado: (2016)

Factors to consider for informed consent prior to vasectomy reversal
por: Kovac, Jason R, et al.
Publicado: (2016)

The importance of understanding baseline reproductive function prior to the administration of exogenous testosterone
por: Kovac, Jason R, et al.
Publicado: (2016)

The importance of sexual function in men with spinal cord injuries
por: Kovac, Jason R, et al.
Publicado: (2016)

Sperm morphology and reproductive success
por: Kovac, Jason R, et al.
Publicado: (2016)

Use of testicular sperm to combat the negative effects of DNA fragmentation
por: Kovac, Jason R, et al.
Publicado: (2016)

The role of advanced paternal age in modern reproductive medicine
por: Wu, Christopher, et al.
Publicado: (2016)

Vasectomy reversal and other strategies to mitigate postvasectomy pain syndrome
por: Smith, Ryan P, et al.
Publicado: (2016)

Advancement of male health is dependent upon updates to insurance coverage for infertility in the United States
por: Smith, Ryan P, et al.
Publicado: (2016)

Is varicocele repair necessary, given the advanced state of assisted reproductive technologies?
por: Smith, Ryan P, et al.
Publicado: (2016)

Stem cells, gene therapy, and advanced medical management hold promise in the treatment of male infertility
por: Smith, Ryan P, et al.
Publicado: (2016)

Estradiol exerts alterations in sexual function and fertility in human males
por: Smith, Ryan P, et al.
Publicado: (2016)

Basic concepts and recent advancements in the study of male fertility
por: Kovac, Jason R, et al.
Publicado: (2016)

Sperm retrieval rates and ICSI outcomes for men with nonobstructive azoospermia and the health of resulting offspring
por: Drobnis, Erma Z
Publicado: (2014)

Azoospermia: vasal agenesis
por: Fisher, J Sam, et al.
Publicado: (2019)

Is There Any Fun in a Puzzle When All Pieces Look the Same?
por: Behrendt, Christian-Alexander
Publicado: (2023)

Men with a complete absence of normal sperm morphology exhibit high rates of success without assisted reproduction
por: Kovac, Jason R, et al.
Publicado: (2017)

Preserving fertility in the hypogonadal patient: an update
por: Ramasamy, Ranjith, et al.
Publicado: (2015)

Clinical management of infertile men with nonobstructive azoospermia
por: Esteves, Sandro C
Publicado: (2015)

The use of “off the shelf” percutaneous deep venous arterialization technology for a patient with severe chronic limb ischemia with no other options for limb salvage
por: Myers, Stuart I.
Publicado: (2023)

The varicocele: diagnostic dilemmas, therapeutic challenges and future perspectives
por: Chiba, Koji, et al.
Publicado: (2016)

Outcome of varicocele repair in men with nonobstructive azoospermia: systematic review and meta-analysis
por: Esteves, Sandro C, et al.
Publicado: (2016)

From azoospermia to macrozoospermia, a phenotypic continuum due to mutations in the ZMYND15 gene
por: Kherraf, Zine-Eddine, et al.
Publicado: (2022)

The Patient-centered Outcomes Research Institute’s Role in Advancing Methods for Patient-centered Outcomes Research
por: Fleurence, Rachael, et al.
Publicado: (2015)

New models for defining prostate cancer biology and patient prognosis
por: Brundage, James, et al.
Publicado: (2021)

“Any fool can make a rule and any fool will mind it”
por: Wells, Athol U.
Publicado: (2016)

Risk-prediction tools in prostate cancer: the challenge of tailoring
por: Morlacco, Alessandro, et al.
Publicado: (2016)

Dexamethasone use in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: this “cort” is not out of order!
por: Van Praet, Charles, et al.
Publicado: (2021)

Commentary: Do you have any doctors in your family?
por: Mays, Jarvis C., et al.
Publicado: (2021)

Development of a Patient-Centered Framework for Oncology Clinicians to Address Uncertainty in Cancer Care During the COVID-19 Pandemic
por: Dhawan, Natasha, et al.
Publicado: (2020)

p27(Kip1) – p(RhoB)lematic in lung cancer
por: Podmirseg, Silvio R, et al.
Publicado: (2019)

Commentary on “Clinical implications of endogenous testosterone density in prostate cancer progression in patients with favorable low and intermediate risk treated with radical prostatectomy”
por: Busetto, Gian Maria, et al.
Publicado: (2023)

Separate Chinese lines for prostate cancer?
por: von Eyben, Finn Edler
Publicado: (2019)

Impact of IL-23 in prostate cancer
por: Mirlekar, Bhalchandra
Publicado: (2021)

Optimal treatment for castration-resistant prostate cancer
por: Izumi, Kouji, et al.
Publicado: (2014)

Serum lipid profiles and aggressive prostate cancer
por: Li, Yanjing, et al.
Publicado: (2015)

Role of frailty assessment in selection for cancer surgery
por: Allum, William H
Publicado: (2022)

Crystalloid or colloid for resuscitation. Are we any the wiser?
por: Webb, Andrew R
Publicado: (1999)

Endo180 at the cutting edge of bone cancer treatment and beyond
por: Sturge, Justin
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nurm7aj0c9r4qjrdvq383pv1ub